Strata Skin Sciences Files Form 25 to Deregister Stock
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 19 2026
0mins
Strata Skin Sciences announces that a Form 25 has been filed today with the SEC to deregister its common stock under Section 12(b) of the Securities Exchange Act of 1934, as amended, and confirms that trading of the company's common stock has been suspended from trading on The Nasdaq Capital Market at the opening of business on February 19. "The pathway taken by the Company was not due to any financial instability of the Company or any weakening in the Company's business," said Dolev Rafaeli, CEO and vice chairman. "In fact, the Company finished the 2025 fiscal year with a very strong balance sheet, which included $8 million in cash."
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
